Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1888 1
1919 2
1921 1
1946 1
1948 1
1950 1
1952 1
1961 1
1971 1
1972 1
1974 1
1976 3
1977 1
1979 2
1980 2
1981 2
1982 1
1983 1
1984 2
1985 3
1986 5
1988 4
1989 2
1990 8
1992 3
1993 2
1994 3
1995 5
1996 3
1997 1
1998 4
1999 1
2000 3
2001 8
2002 8
2003 4
2004 6
2005 9
2006 7
2007 7
2008 10
2009 7
2010 5
2011 12
2012 10
2013 11
2014 9
2015 19
2016 15
2017 29
2018 28
2019 30
2020 37
2021 26
2022 30
2023 16
2024 23
2025 23
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

426 results

Results by year

Filters applied: . Clear all
Page 1
The serotonin syndrome.
Boyer EW, Shannon M. Boyer EW, et al. N Engl J Med. 2005 Mar 17;352(11):1112-20. doi: 10.1056/NEJMra041867. N Engl J Med. 2005. PMID: 15784664 Review. No abstract available.
Dextromethorphan abuse.
Boyer EW. Boyer EW. Pediatr Emerg Care. 2004 Dec;20(12):858-63. doi: 10.1097/01.pec.0000148039.14588.d0. Pediatr Emerg Care. 2004. PMID: 15572980 Review.
Chimeric antigen receptor T-cell toxicity.
Baymon DE, Boyer EW. Baymon DE, et al. Among authors: boyer ew. Curr Opin Pediatr. 2019 Apr;31(2):251-255. doi: 10.1097/MOP.0000000000000747. Curr Opin Pediatr. 2019. PMID: 30762706 Review.
Discovery of stimulation-responsive immune enhancers with CRISPR activation.
Simeonov DR, Gowen BG, Boontanrart M, Roth TL, Gagnon JD, Mumbach MR, Satpathy AT, Lee Y, Bray NL, Chan AY, Lituiev DS, Nguyen ML, Gate RE, Subramaniam M, Li Z, Woo JM, Mitros T, Ray GJ, Curie GL, Naddaf N, Chu JS, Ma H, Boyer E, Van Gool F, Huang H, Liu R, Tobin VR, Schumann K, Daly MJ, Farh KK, Ansel KM, Ye CJ, Greenleaf WJ, Anderson MS, Bluestone JA, Chang HY, Corn JE, Marson A. Simeonov DR, et al. Among authors: boyer e. Nature. 2017 Sep 7;549(7670):111-115. doi: 10.1038/nature23875. Epub 2017 Aug 30. Nature. 2017. PMID: 28854172 Free PMC article.
[Oral microbiota and liver].
Lê S, Minty M, Boyer É, Blasco-Baque V, Bonnaure-Mallet M, Meuric V. Lê S, et al. Among authors: boyer e. Med Sci (Paris). 2024 Jan;40(1):42-48. doi: 10.1051/medsci/2023194. Epub 2024 Feb 1. Med Sci (Paris). 2024. PMID: 38299902 Free article. French.
The olfactory epithelium: a critical gateway for pathological tau propagation and a target for mitigating tauopathy in the central nervous system.
Dourte M, Paître E, Bouchoucha M, Boyer E, Tomé SO, Doeraene E, Huart C, Leroy K, Thal DR, Decottignies A, Hanseeuw B, Suelves N, Kienlen-Campard P. Dourte M, et al. Among authors: boyer e. Acta Neuropathol. 2025 Jun 19;149(1):64. doi: 10.1007/s00401-025-02902-6. Acta Neuropathol. 2025. PMID: 40536690 Free PMC article.
Serious Illness Conversations in the Emergency Department for Older Adults With Advanced Illnesses: A Randomized Clinical Trial.
Ouchi K, Block SD, Rentz DM, Berry DL, Oelschlager H, Shiozawa Y, Rossmassler S, Berger AL, Hasdianda MA, Wang W, Boyer E, Sudore RL, Tulsky JA, Schonberg MA. Ouchi K, et al. Among authors: boyer e. JAMA Netw Open. 2025 Jun 2;8(6):e2516582. doi: 10.1001/jamanetworkopen.2025.16582. JAMA Netw Open. 2025. PMID: 40531532 Free PMC article. Clinical Trial.
Porphyromonas gingivalis outside the oral cavity.
Bregaint S, Boyer E, Fong SB, Meuric V, Bonnaure-Mallet M, Jolivet-Gougeon A. Bregaint S, et al. Among authors: boyer e. Odontology. 2022 Jan;110(1):1-19. doi: 10.1007/s10266-021-00647-8. Epub 2021 Aug 19. Odontology. 2022. PMID: 34410562 Free article. Review.
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review.
Eshmuminov D, Aminjonov B, Palm RF, Malleo G, Schmocker RK, Abdallah R, Yoo C, Shaib WL, Schneider MA, Rangelova E, Choi YJ, Kim H, Rose JB, Patel S, Wilson GC, Maloney S, Timmermann L, Sahora K, Rössler F, Lopez-Lopez V, Boyer E, Maggino L, Malinka T, Park JY, Katz MHG, Prakash L, Ahmad SA, Helton S, Jang JY, Hoffe SE, Salvia R, Taieb J, He J, Clavien PA, Held U, Lehmann K. Eshmuminov D, et al. Among authors: boyer e. Ann Surg Oncol. 2023 Jul;30(7):4417-4428. doi: 10.1245/s10434-023-13353-2. Epub 2023 Apr 5. Ann Surg Oncol. 2023. PMID: 37020094 Free PMC article.
426 results